Brown & Brown (BRO) recently affirmed a quarterly cash dividend of $0.15 per share, payable on August 20, 2025. Over the last week, the company's stock price moved slightly by 1.71%, while the broader market rose by 1.7%. This dividend declaration signifies the company's ongoing commitment to shareholder value, but the market dynamics suggest the effect on the share price was minimal, contributing to broader market trends instead. While the market has seen a significant 18% rise over the past year, Brown & Brown's recent performance aligns closely with the general upward trajectory.
We've spotted 1 weakness for Brown & Brown you should be aware of.
The recent dividend declaration by Brown & Brown, Inc. reinforces its commitment to shareholder value, but with the stock price incrementally moving by 1.71% in a week of market-wide gains, its immediate impact on the company's valuation appears minimal. Over five years, Brown & Brown's total shareholder return, inclusive of share price appreciation and dividends, reached 137.41%. Despite this substantial long-term performance, the company's one-year showing was weaker, underperforming the broader US Insurance industry, which saw a return of 9.8% over the past year.
With an affirmed dividend and the share price currently at US$103.18, the potential upward movement toward the analyst consensus price target of US$120.18 places the stock at a discount of approximately 16.48%. This indicates optimism aligned with expectations of revenue and earnings growth, driven by acquisitions and effective financial management. Analysts expect revenue and earnings to grow significantly in the years ahead, though with narrowing profit margins. The dividend's confirmation may bolster investor confidence in these forecasts, but it underscores the importance of the company's ability to manage economic and operational challenges to reach projected targets.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Brown & Brown might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com